Loading organizations...
§ Venture Capital · Tel Aviv, Israel
Newbury Acquisitions Fund, often with Infinity CSVC Management, is an investment firm providing capital and strategic guidance to emerging companies. It targets high-potential businesses in life sciences and advanced technology, offering resources and expertise. This accelerates development and market presence through active support for its portfolio.
This collaborative investment approach arises from strategic alignments between entities like Infinity Group and Suzhou Oriza Holdings Corporation, co-managing the Infinity-CSVC Fund. This model combines capital and expertise for promising ventures. Professionals such as Elka Nir previously directed specialized strategies as Managing Director for life sciences, reflecting a targeted focus.
Newbury Acquisitions Fund and Infinity CSVC Management serve companies needing investment for commercialization and market expansion. Their vision is to cultivate impactful enterprises, generating substantial investor returns. They empower businesses to achieve sustained growth, aiming to be pivotal partners in long-term success.
Newbury Acquisitions Fund/Infinity CSVC Management has 1 tracked investment across 1 company. The latest tracked deal is $31.0M Series E in VisionCare Ophthalmic Technologies in January 2011.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2011 | VisionCare Ophthalmic Technologies | $31.0M Series E | Saints Capital | Norwest Venture Partners, BSI, General Ifinancial Holdings, Elka NIR, ONSET Ventures, Pitango Venture Capital, Three Arch Partners |